| (+)-BAY-7081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| (+)-EMD 57033 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| (+)-Medioresinol Di-O-β-D-glucopyranoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.99% |
| (-)-Deacetylsclerotiorin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (-)-Pimobendan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1R,2R)-Elpipodect |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (E/Z)-Ensifentrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (E/Z)-HA155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| (E/Z)-N-Desethylsunitinib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-(-)-Rolipram |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| (R)-Avanafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-DNMDP |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| (R)-Irsenontrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.00% |
| (R)-Tanimilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| (R)-Xanthoanthrafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (R)-Apremilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| (Rac)-Apremilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| (rac)-Nerandomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-PDE4-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Tovinontrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (Rac)-Apremilast-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (S)-(+)-Rolipram |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| (S)-BAY 73-6691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| (S)-BRD9500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| (S)-C33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| (S)-Gebr32a |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.97% |
| (S)-Nerandomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| (S)-PF-04449613 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| (±)-BAY-7081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| 1,3,5-Trihydroxy-4-prenylxanthone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1-Phenyl-3,4-dihydroisoquinoline |
|
|
|
|
|
|
|
|
|
|
|
|
|
96.0% |
| 2',3'-Cyclic NADP disodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2'-O-MB-cGMP sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3′,5′-Cyclic nucleotide phosphodiesterase |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3,5,6,7,8,3',4'-Heptemthoxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| 3-O-Methylquercetin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| 4'-Methoxyisoagarotetrol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Nitrophenyl phenylphosphonate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| 4-Pentadecylbenzylphosphonic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parogrelil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,5′-(1,3-Propanediyl)bis-1,3,4-oxadiazole-2(3H)-thione |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,6-DCl-cBIMP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,6-DM-cBIMP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,7-Diacetoxy-8-methoxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.04% |
| 5,7-Dichloropyrazolo[1,5-a]pyrimidine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| 6-Cl-cPuMP sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 8-CPT-Cyclic AMP sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| AA 2379 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acefylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acefylline piperazine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AChE/PDE4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Adafenoxate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Adibendan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADORA2A/PDE4D-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AGS-16C3F |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Aildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.46% |
| Aildenafil-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Albifylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amentoflavone hexaacetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AMG 579 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.95% |
| AMG-7980 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AMG580 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amrinone lactate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AN-2898 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AN3199 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Anagrelide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Anagrelide-13C2,15N,d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Andolast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Andolast free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.37% |
| Antitumor agent-100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-100 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Archangelicin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aristolochic acid D |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Arofylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASB16165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASP9436 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASP9831 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atherosperminine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATI22-107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Atizoram |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| ATX inhibitor 10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| ATX inhibitor 12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.20% |
| ATX inhibitor 7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX inhibitor 9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX-1905 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATX-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Autotaxin modulator 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| Autotaxin-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Autotaxin-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| Autotaxin-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Autotaxin-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Autotaxin-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Autotaxin-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Autotaxin-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avanafil dibenzenesulfonate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avanafil metabolite M4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avanafil-13C5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AWD 12-281 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.07% |
| AY 25674 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ayanin |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.18% |
| Balipodect |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| BAY 2666605 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Bay 60-7550 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.39% |
| BAY 73-6691 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| BAY 73-6691 racemate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| BAY-7081 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| BC-54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BC11-38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| BC12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BC8-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bemoradan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benafentrine maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BI-2545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.85% |
| BIO-32546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| BJH-86 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BL-122 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BML-288 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-341400 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMS-341400 mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BMY 20844 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRD9500 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.41% |
| BRL-50481 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| BrP-LPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BrP-LPA sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BW-A 78U |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| CALP1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| CALP1 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.15% |
| Carbazeran |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Carbodenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| Catramilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CBS-3595 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CC-3052 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CD00509 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| CD73-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDC801 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| CdnP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDP-840 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CGH2466 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CI-1044 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| Cipamfylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cirsimarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| CK-2289 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CK-3197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clozic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-414 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-545 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CM-675 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| CP-220629 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CP671305 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| CPL500036 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cudetaxestat |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.32% |
| Cys-TAT-HA2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| D(+)-Raffinose pentahydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| D-4418 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| D159153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| D159687 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.42% |
| Dasantafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.35% |
| Davalomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dazonone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deacetylsclerotiorin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltaflexin3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltafluorine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltarasin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.12% |
| Deltarasin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltarasin trihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltasonamide 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.15% |
| Deltasonamide 1 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltasonamide 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Deltasonamide 2 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.78% |
| Deltasonamide 2 TFA |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Deltazinone 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.79% |
| Denbufylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Desmethyl thiosildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Difamilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| Diniprofylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DN-9693 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DNMDP |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| DNS-8254 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dovramilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| DPN-205-734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Drotaverine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Drotaverine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Drotaverine-d10 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DSR-141562 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| DTA |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| E6 Berbamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Edelinontrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Efmirenpase alfa |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Eggmanone |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.31% |
| EHNA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EHNA hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| EL244 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| Elpipodect |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.95% |
| EMD 53998 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| EMD 57439 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| endo CNTinh-03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Enpp-1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.19% |
| Enpp-1-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.64% |
| Enpp-1-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Enpp-1-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| Enpp-1-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.46% |
| Enpp-1-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Enpp-1-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Enpp-1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Enpp-1-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.06% |
| Enpp-1-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.07% |
| Enpp-1-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.16% |
| Enpp-1-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp-1/3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Enpp/Carbonic anhydrase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Enpp/Carbonic anhydrase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.48% |
| ENPP3 Inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Ensifentrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.36% |
| Ensifentrine tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ent-Tadalafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.17% |
| ER21355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ER21355 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Etazolate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Etazolate hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| Eurycomanone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| FCPR03 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| FCPR16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Filaminast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FPFT-2216 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| FR-181074 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FR-229934 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| GEBR-7b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gemlapodect |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GLUT4 activator 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GPD-1116 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GPR61 Inverse agonist 3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GRI918013 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Griseolic acid B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GS-5759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| GSK256066 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| GSK256066 Trifluoroacetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| GSK356278 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| GSK4394835A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HA130 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.79% |
| HA155 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.50% |
| Hcyb1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.20% |
| Hedgehog IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hellicoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hexadecyl 2-((4-Nitrophenyl)thio)acetate-13C2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hoquizil hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HT-0712 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HY-072808 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.75% |
| Hydronidone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| Hydroxychlorodenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.6% |
| IBMX |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| IBMX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ICI 153110 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ICI-170777 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ICI-63197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| ID11916 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Imazodan hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Indimilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Indolidan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Irsenontrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Irsenontrine maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isbufylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ISM5939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Isomazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isomazole hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isopedicin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ITI-214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| ITI-214 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| JNJ-10258859 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JNJ-42259152 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JNJ-42314415 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JNJ-42396302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JNJ-54082730 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| K-252d |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| K-Ras-PDEδ-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| K134 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| KCA-1490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KD-027 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KF-17625 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KMUP-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KMUP-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KR-40795 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KRAS IN-44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KS 619-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Kushenol B |
|
|
|
|
|
|
|
|
|
|
|
|
|
96% |
| Kushenol Z |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KVA-D-88 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| KW-4490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L-6355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L-869298 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L791943 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Laprafylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LAS-31180 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LASSBio-1632 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Leniquinsin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LEO 29102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LEO 39652 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| LH17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lirimilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.69% |
| Lixazinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lixazinone hydrogensulfate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lodenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Lodenafil carbonate |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Longestin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lotamilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| LT-104A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lunamarine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LY 186126 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LY2775240 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| M3/PDE4 modulator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mangostanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mardepodect |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.81% |
| Mardepodect hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Mardepodect precursor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mardepodect succinate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MBCQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| MDL 19205 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MDL3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menabitan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Menabitan dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Meribendan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mesembranol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mesopram |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.80% |
| MEY-003 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MHC00188 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MHC02181 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MK-0359 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MK-0873 |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| MK-0952 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| MK-0952 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ML-030 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Mopidamol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Morcamilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.92% |
| MP 518 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MR-L2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.37% |
| MS 857 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MT-3014 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mufemilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| Multitarget AD-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MY-5445 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| N-Desethyl-N-methyl vardenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Desmethyl Sildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| N-Desmethyl Sildenafil-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Methylbenzamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Nanterinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Nanterinone mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Naperiglipron |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Nauclefine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| NCI-14465 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nelvutamig |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.76% |
| Nerandomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Nerandomilast dihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Neuroprotective agent 12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NHTD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nicotinamide 1,N6-ethenoadenine dinucleotide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| Nicotinamide 1,N6-ethenoadenine dinucleotide (solution) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nitraquazone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nor-Acetildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nor-Acetildenafil-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NPD-001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| NPD-1335 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| NPP1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| NSC-88915 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NSP-805 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| NTPDase/NPP1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nummularine B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NVP-ABE171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Obscurolide A1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Oglemilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| ONO-6126 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ONO-8430506 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| OPB-171775 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| OPC 33540 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ophiobolin A |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| OR-1896 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.04% |
| OR-1896-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ORG-20241 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Org-9935 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Orismilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Osoresnontrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Oxagrelate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| P2Y12/PDE5-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| P7-2104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| P7–2302 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Palmitoleoyl 3-carbacyclic phosphatidic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Palmitoylcholine chloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| PAT-048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PAT-078 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PAT-347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| PAT-347 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PAT-505 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.48% |
| PAT-505 (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PBF-999 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.89% |
| PDE IV-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE-9 inhibitor |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| PDE-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE/TRPA1/CHIT1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| PDE1-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| PDE1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE1-IN-9 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE10-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| PDE10-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE10-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| PDE10-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE10A-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE10A-IN-2 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.43% |
| PDE10A-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE10A-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE10A-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE11-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.23% |
| PDE11A modulator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE11A4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE11A4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE12 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pde12 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pde12 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE12-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| PDE12-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| PDE2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE2A-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE2A-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE2A-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| PDE3/4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| PDE3/4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE3/4-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE3B-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| PDE4-IN precursor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.84% |
| PDE4-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| PDE4-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-32 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4/5-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B modulator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.28% |
| PDE4B-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| PDE4B-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| PDE4B-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B/7A-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.63% |
| PDE4B/7A-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B/D-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4B/D-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE4D inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| PDE5-IN-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-6c |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| PDE5-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| PDE5/CA-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE5/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE7-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
≥99.0% |
| PDE7-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| PDE7-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.55% |
| PDE7A-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| PDE8B-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| PDE8B-IN-1 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDE9-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| PDE9-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDEδ autophagic degrader 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDEδ-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDEδ/NAMPT IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDM-042 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PDM-631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pelrinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-00489791 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| PF-03049423 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-03049423 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-04449613 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| PF-04471141 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-04677490 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-04822163 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-04827736 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-04957325 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| PF-05085727 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| PF-05180999 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| PF-06445974 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.59% |
| PF-06445974 precursor |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| PF-06815189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-07038124 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PF-07038124 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.26% |
| PF-8380 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| PF-8380 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| Phenacaine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Phosphodiesterase 10-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase l, Rattlesnake venom |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phyllodulcin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Piclamilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| PQ-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| Prinoxodan |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| Propentofylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Propentofylline-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Propoxyphenyl Aildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC PDE4 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pumafentrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PyP-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quazinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.7% |
| Quazodine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| R 80123 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| R-836 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RA642 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reproterol |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.94% |
| Reproterol hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reproterol-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Reticulol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revamilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Revizinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| Ro 20-1724 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Ro-15-2041 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Roflupram |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Rolipram |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ronomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RS-25344 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RS-25344 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| RS14203 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RX-RA-69 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S-Petasin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S32826 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S32826 disodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.85% |
| SAL-0010042 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sappanone A |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| SAR156497 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Saterinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SCA-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SCH 351591 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| SCH 51866 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SCH-1518291 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sch59498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SDZ-MKS 492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Sequosempervirin B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Siguazodan |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| Sildenafil chlorosulfonyl |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Sildenafil-d3N-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| SMQ-03-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sp-cAMPS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sp-cAMPS sodium salt |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Sp-cAMPS triethylamine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sphingomyelin phosphodiesterase, Bacillus cereus |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STF-1084 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| STF-1623 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Sudachitin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| T-0156 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| T-0156 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| T-1032 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| T-1032 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tadalafil-13C2,d3-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TAK-915 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Talaroterphenyl A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tanimilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.71% |
| TC-E 5005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TDP1 Inhibitor-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.33% |
| TDP1 Inhibitor-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| TDP1 Inhibitor-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| TDP1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TDP1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TDP1-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tetomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.15% |
| TGF-β/Smad-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theodrenaline hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theophylline L-lysine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thioquinapiperifil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thioquinapiperifil dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| THPP-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.75% |
| THPP-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tibenelast free acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tilivapram |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Tiropramide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tiropramide-d5 oxalate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TM-04-064-02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TMX-4100 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.26% |
| TMX-4113 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| Toborinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tofimilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tolafentrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Torbafylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tovinontrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| TP-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| TPN171 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.10% |
| TPN729 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TPN729MA |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Traxanox |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trequinsin hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| TX-2552 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| TyK2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.05% |
| U 84569 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UK 343664 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UK 357903 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UK-1745 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UK-371800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UK-500001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| V11294 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vizenpistat |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| VP3.15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VP3.15 dihydrobromide |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| W-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.35% |
| W-7 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| WAY127093B racemate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Win 58237 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Win-62005 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| WIN-63291 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Xanthoanthrafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Xanthoanthrafil-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Y-20487 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YM976 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Yonkenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Yonkenafil hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Z19153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Z21090 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Z21115 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Zatolmilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.50% |
| Zindotrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ziritaxestat |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| β-Carboline-1-carboxylic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Triflusal |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| Triflusal-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Udenafil-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Udenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Acetylvardenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theophylline sodium acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Diphylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.22% |
| 12-epi-Tadalafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| cis-Tadalafil-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (6S,12aR)-Tadalafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| Tadalafil-13C2,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tadalafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Ipenoxazone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Irsogladine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Imazodan |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.38% |
| Vardenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Vardenafil-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vardenafil dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vardenafil-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vardenafil hydrochloride trihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.67% |
| Crisaborole-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.8% |
| Crisaborole |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| MMPX |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sildenafil Mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pimobendan |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| Pimobendan-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Pimobendan-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Carbazeran citrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tadalafil-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| Nortadalafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Norbraylin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dipyridamole-d20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dipyridamole-d16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dipyridamole |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Dipyridamole Mono-O-β-D-glucuronide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Senazodan |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Senazodan hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Gisadenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gisadenafil-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gisadenafil besylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.60% |
| Pyrazole N-Desmethyl sildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Furamidine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Furamidine dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Rolipram |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Doxofylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Doxofylline-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Doxofylline-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| Robustine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Olprinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| Ambuphylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Levosimendan |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Pentoxifylline-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Pentoxifylline-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.0% |
| Pentoxifylline-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pentoxifylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Braylin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parogrelil hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ibudilast-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ibudilast-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ibudilast-d7-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ibudilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Enprofylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.71% |
| Ensifentrine-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Zaprinast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| Zardaverine |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.59% |
| Tofisopam |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Tofisopam (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |
| Trapidil |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Trequinsin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tiropramide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mesembrine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Pinoresinol 4-O-β-D-glucopyranoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Moracin M |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.99% |
| Sophoflavescenol |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.78% |
| Kuraridine |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Amrinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Etofylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| Aminophylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Saterinone hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Glaucine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| Icariin (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.21% |
| Icariin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| Enoximone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Dihydroergotoxine mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| Fraxin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Vardenafil-d5 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.65% |
| Vardenafil hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Pimobendan hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Olprinone Hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| Anagrelide hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.39% |
| Tibenelast sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Phosphodiesterase I |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Phosphodiesterase II, Bovine Spleen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Milrinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Milrinone-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Milrinone lactate |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.76% |
| Mirodenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Mirodenafil-d7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mirodenafil dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.11% |
| Butein |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| Vesnarinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.52% |
| Roflumilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Roflumilast-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.26% |
| Roflumilast-d4 N-Oxide |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.13% |
| Roflumilast-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Roflumilast N-oxide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Roflumilast Impurity E |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.37% |
| Medorinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proxyphylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Atherosperminine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fenspiride-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fenspiride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fenspiride hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Theophylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Theophylline-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| Theophylline (Standard) |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Theophylline-13C2,d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theophylline-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acefylline |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| Theophylline monohydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.93% |
| Theodrenaline |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Motapizone |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| Tribuloside |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.95% |
| Sildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Sildenafil-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Sildenafil-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sildenafil-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Desethyl sildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sildenafil-d3 citrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sildenafil citrate-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sildenafil citrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Cilostazol |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Cilostazol-d11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cilostazol-d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cilostazol-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cilomilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Cilostamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.13% |
| Homo Sildenafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| Homo Sildenafil-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vinpocetine-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Vinpocetine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| Avanafil-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avanafil-13C5,15N,d2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avanafil-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Avanafil |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.00% |
| Apremilast |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Apremilast-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.26% |
| Apremilast-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Apremilast-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anagrelide hydrochloride monohydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ilexsaponin B2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.47% |
| Irsogladine maleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |